Inventor · disambiguated record
Julian Levell
Also filed as: LEVELL JULIAN · LEVELL JULIAN R · LEVELL JULIAN ROY
19 granted patents·16 pending applications·249 citations·filing 1996–2024
94Inventor score
Files withCONSTELLATION PHARMACEUTICALS INC11AVENTIS PHARMA INC4CAFERRO THOMAS RAYMOND3CENTAUR PHARMACEUTICALS INC3BRAIN CHRISTOPHER THOMAS2
Top patents by PatentIndex Score
35 records- 0188US9309252B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2014·Granted Apr 12, 2016·12 cites·18 claims
- 0288US6281227B1Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compoundsAVENTIS PHARMA GMBH·Filed 1999·Granted Aug 28, 2001·44 cites·34 claims
- 0385US8957068B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2012·Granted Feb 17, 2015·13 cites·28 claims
- 0485US8957074B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2011·Granted Feb 17, 2015·9 cites·40 claims
- 0585US6046232Aα-aryl-N-alkylnitrones and pharmaceutical compositions containing the sameCENTAUR PHARMACEUTICALS INC·Filed 1998·Granted Apr 4, 2000·49 cites·51 claims
- 0684US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 0784US6977263B2Chemical compoundsAVENTIS PHARMA INC·Filed 2001·Granted Dec 20, 2005·27 cites·59 claims
- 0884US5955520APhotochromic indeno-fused naphthopyransPPG INDUSTRIES INC·Filed 1996·Granted Sep 21, 1999·72 cites·25 claims
- 0980US9688672B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
- 1078US6441032B1Alpha-(4-Ethoxyphenyl)-N-tert-butylnitrone, pharmaceutical compositions and their medical useCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Aug 27, 2002·7 cites·8 claims
- 1175US2025230137A1P300/cbp hat inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1273US6433008B1α-aryl-N-alkylnitrones and pharmaceutical compositions containing the sameCENTAUR PHARMACEUTICALS INC·Filed 2000·Granted Aug 13, 2002·5 cites·17 claims
- 1373US2025136588A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1463US7947684B21-aroyl-piperidinyl benzamidinesAVENTIS PHARMA INC·Filed 2003·Granted May 24, 2011·2 cites·12 claims
- 1560US12172990B2Modulators of TREX1CONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Dec 24, 2024·0 cites·19 claims
- 1660US11274090B2P300/CBP HAT inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Mar 15, 2022·0 cites·24 claims
- 1759US2014275083A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCAFERRO THOMAS RAYMOND·Filed 2014·Application pending·0 cites
- 1857US10112931B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2017·Granted Oct 30, 2018·0 cites·11 claims
- 1957US2024246946A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2057US2005124691A1Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the sameFiled 2004·Application pending·0 cites
- 2156US2024262814A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2255US8183231B2Substituted propane phosphinic acid derivativesCHOI-SLEDESKI YONG MI·Filed 2006·Granted May 22, 2012·0 cites·34 claims
- 2353US11459315B2Modulators of methyl modifying enzymes, compositions and uses thereofCONSTELLATION PHARMACEUTICALS INC·Filed 2018·Granted Oct 4, 2022·0 cites·11 claims
- 2452US2003087957A1Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the sameFiled 2002·Application pending·0 cites
- 2551US2022331304A1Compounds for use in treating neurological disordersCONSTELLATION PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2648US11414384B2P300/CBP hat inhibitorsCONSTELLATION PHARMACEUTICALS INC·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 2748US8828974B2Substituted propane phosphinic acid derivativesCHOI-SLEDESKI YONG MI·Filed 2012·Granted Sep 9, 2014·0 cites·20 claims
- 2848US2023233541A1Substituted benzamides as modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2947US2023167070A1Modulators of trex1CONSTELLATION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3046US2016312311A1Markers for isocitrate dehydrogenase inhibitorsLIN FALLON·Filed 2014·Application pending·0 cites
- 3144US2007142435A1[4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptaseAVENTIS PHARMA INC·Filed 2006·Application pending·0 cites
- 3243US2002013310A1Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compoundsFiled 2001·Application pending·0 cites
- 3341US2002045613A11-aroyl-piperidinyl benzamidinesFiled 2001·Application pending·0 cites
- 3439US2005228018A1Chemical compoundsAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
- 3539US2016039802A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCHO YOUNG SHIN·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Julian Levell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →